Gyre Therapeutics (GYRE) Stock Chart & Stock Price History → “Dollar Will Be Worth NOTHING” -Musk (From Crypto 101 Media) (Ad) Free GYRE Stock Alerts $14.43 -0.86 (-5.62%) (As of 12:00 PM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Gyre Therapeutics Stock Price Performance5 Day Performance+3.17%1 Month Performance-3.47%3 Month Performance-0.59%6 Month Performance+3.94%Year-To-Date Performance-40.48% Receive GYRE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Gyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 Media“Dollar Will Be Worth NOTHING” -MuskElon Musk just issued an urgent warning… Saying “The U.S. Dollar will be worth NOTHING…” As "stealth money printing" pushes the price of Bitcoin, Ethereum, XRP and crypto higher.Click here to claim your free seat ticket now. GYRE Stock Chart for Friday, May, 17, 2024 GYRE Chart by TradingView Gyre Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/16/2024$15.63$15.29-2.18%$15.91$15.1738,055 shs$1.31 billion05/15/2024$15.77$15.63-0.89%$15.95$15.5057,104 shs$1.34 billion05/14/2024$15.75$15.77+0.13%$15.99$15.2348,058 shs$1.35 billion05/13/2024$14.82$15.75+6.28%$15.88$14.5251,566 shs$1.35 billion05/10/2024$15.23$14.82-2.69%$15.66$14.7138,283 shs$1.27 billion05/09/2024$15.69$15.23-2.93%$15.69$15.2345,150 shs$1.30 billion Get the Latest News and Ratings for GYRE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/08/2024$14.82$15.69+5.87%$15.84$14.5243,333 shs$1.34 billion05/07/2024$14.82$14.82$15.14$14.6748,224 shs$1.27 billion05/06/2024$15.14$14.82-2.11%$15.19$14.8141,632 shs$1.27 billion05/03/2024$14.10$15.14+7.38%$15.15$14.0036,533 shs$1.29 billion05/02/2024$13.86$14.10+1.73%$15.72$13.8190,458 shs$1.21 billion05/01/2024$15.60$13.86-11.15%$15.70$13.50125,154 shs$1.18 billion04/30/2024$16.43$15.60-5.05%$16.48$15.4334,451 shs$1.33 billion04/29/2024$17.11$16.43-3.97%$17.11$16.1136,060 shs$1.40 billion04/26/2024$16.33$17.11+4.78%$17.25$15.90190,123 shs$1.46 billion04/25/2024$16.05$16.33+1.74%$16.78$15.35137,161 shs$1.39 billion04/24/2024$15.94$16.05+0.69%$16.27$15.6331,808 shs$1.37 billion04/23/2024$15.96$15.94-0.13%$16.15$15.5339,480 shs$1.36 billion04/22/2024$15.51$15.96+2.90%$16.44$15.5266,005 shs$1.36 billion04/19/2024$15.41$15.51+0.65%$15.81$14.5958,832 shs$1.32 billion04/18/2024$15.84$15.41-2.71%$15.95$15.1038,055 shs$1.32 billion04/17/2024$16.00$15.84-1.00%$16.42$15.2642,070 shs$1.35 billion04/16/2024$16.48$16.00-2.91%$16.26$15.7955,505 shs$1.37 billion04/15/2024$16.81$16.48-1.96%$16.81$16.0048,999 shs$1.41 billion04/12/2024$16.45$16.81+2.19%$17.05$15.7862,603 shs$1.44 billion04/11/2024$13.88$16.45+18.52%$17.00$14.25120,471 shs$1.41 billion04/10/2024$17.00$13.88-18.35%$17.00$13.32221,494 shs$1.19 billion04/09/2024$16.86$17.00+0.83%$17.05$16.6151,769 shs$1.45 billion04/08/2024$16.95$16.86-0.53%$17.09$16.6862,248 shs$1.44 billion04/05/2024$16.98$16.95-0.18%$17.12$16.6559,958 shs$43.14 million04/04/2024$17.16$16.98-1.05%$17.33$16.2176,705 shs$43.13 million04/03/2024$16.99$17.16+1.00%$17.18$16.1360,581 shs$43.59 million04/02/2024$15.85$16.99+7.19%$17.00$15.5653,609 shs$43.16 million04/01/2024$17.48$15.85-9.32%$17.49$15.8070,470 shs$40.26 million03/29/2024$17.48$17.48$18.33$17.0772,408 shs$44.40 million03/28/2024$17.53$17.48-0.29%$18.33$17.0772,408 shs$44.40 million03/27/2024$16.79$17.53+4.41%$17.93$16.2171,488 shs$44.53 million03/26/2024$16.18$16.79+3.77%$17.77$16.4568,093 shs$42.65 million03/25/2024$17.59$16.18-8.02%$17.94$16.1539,744 shs$41.18 million03/22/2024$17.81$17.59-1.24%$18.18$17.1326,356 shs$44.50 millionShocking $16T Elon Musk Crypto Leak (Ad)There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.Click here for all the details…03/21/2024$17.86$17.81-0.28%$18.20$17.2937,031 shs$45.06 million03/20/2024$18.22$17.86-1.98%$18.55$17.4455,385 shs$45.24 million03/19/2024$18.15$18.22+0.39%$18.68$17.7074,429 shs$46.10 million03/18/2024$16.76$18.15+8.29%$18.38$16.7037,508 shs$45.92 million03/15/2024$18.82$16.76-10.95%$19.96$15.9177,063 shs$42.45 million03/14/2024$19.01$18.82-1.00%$19.85$18.2141,370 shs$47.62 million03/13/2024$17.65$19.01+7.71%$19.35$17.3542,173 shs$48.10 million03/12/2024$16.33$17.65+8.08%$17.96$16.2514,879 shs$44.65 million03/11/2024$17.24$16.33-5.28%$17.96$16.3230,482 shs$41.36 million03/08/2024$19.52$17.24-11.68%$20.09$16.5869,046 shs$43.62 million03/07/2024$20.68$19.52-5.61%$21.17$19.5141,815 shs$49.39 million03/06/2024$20.42$20.68+1.27%$20.98$19.8917,285 shs$52.38 million03/05/2024$21.55$20.42-5.24%$22.00$20.2033,703 shs$51.66 million03/04/2024$20.58$21.55+4.71%$21.83$19.6954,104 shs$54.52 million03/01/2024$18.14$20.58+13.45%$20.93$16.5071,954 shs$52.07 million02/29/2024$24.79$18.14-26.83%$22.90$18.14170,985 shs$45.89 million02/28/2024$22.72$24.79+9.11%$25.94$22.0196,303 shs$62.72 million02/27/2024$25.05$22.72-9.30%$26.37$22.3782,544 shs$57.48 million02/26/2024$22.03$25.05+13.71%$25.05$22.02131,688 shs$63.38 million02/23/2024$16.00$22.03+37.69%$24.07$15.75378,495 shs$55.74 million02/22/2024$14.13$16.00+13.23%$16.47$14.0763,118 shs$40.48 million02/21/2024$15.14$14.13-6.67%$15.30$13.5543,974 shs$35.79 million02/20/2024$15.38$15.14-1.56%$16.59$14.2978,381 shs$38.30 million02/19/2024$15.38$15.38$18.50$15.33120,600 shs$38.91 million02/16/2024$15.97$15.38-3.69%$18.50$15.33120,645 shs$38.96 million Related Companies: Xencor Stock Chart ANI Pharmaceuticals Stock Chart Pacira BioSciences Stock Chart Kiniksa Pharmaceuticals Stock Chart Belite Bio Stock Chart Day One Biopharmaceuticals Stock Chart Dynavax Technologies Stock Chart Akero Therapeutics Stock Chart Avadel Pharmaceuticals Stock Chart MannKind Stock Chart Receive GYRE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Gyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GYRE) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldObama’s Forever Term [exposed]Porter & CompanyDems have chosen Biden replacement?Paradigm PressDoes this make you sick?Allegiance GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge Alerts348 million Americans lives to END as we know it?The Oxford ClubMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gyre Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.